Considering the predisposition of HHT-ECs toward decreased viability, we assessed endogenous cell stability by performing a TUNEL assay and analyzing the expression of cleaved caspase-3. The gene discussed is CASP3; the disease is hereditary hemorrhagic telangiectasia.